Liposomal Lactoferrin Exerts Antiviral Activity against HCoV-229E and SARS-CoV-2 Pseudoviruses In Vitro

A limited number of effective therapies are currently available to treat human coronavirus SARS-CoV-2 and other human coronaviruses, which are responsible for nearly a third of global cases of the common cold. The possibility of new emerging coronaviruses demands powerful new antiviral strategies. L...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreu, Sabina, Ripa, Inés, Bello-Morales, Raquel, López-Guerrero, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142420/
https://www.ncbi.nlm.nih.gov/pubmed/37112952
http://dx.doi.org/10.3390/v15040972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142420/
https://www.ncbi.nlm.nih.gov/pubmed/37112952
http://dx.doi.org/10.3390/v15040972

Ejemplares similares